Literature DB >> 9131454

Infection with GB virus C and hepatitis C virus in hemodialysis patients and blood donors in Beijing.

Y Wang1, H S Chen, M H Fan, H L Liu, P An, N Sawada, T Tanaka, F Tsuda, H Okamoto.   

Abstract

RNAs of GB virus C (GBV-C) and hepatitis C virus (HCV) were sought by reverse-transcription polymerase chain reaction with nested primers deduced from the 5' untranslated region: 79 patients on maintenance hemodialysis, 205 commercial blood donors, and 205 voluntary donors in Beijing were studied. GBV-C RNA was detected in 43 (54%) patients and 17 (8%) commercial donors, and HCV RNA in 43 (54%) patients and 13 (6%) commercial donors, respectively. By contrast, GBV-C RNA was detected only in 2 (1%) and HCV RNA in none among 205 volunteer blood donors serving as controls. Thus both patients and commercial blood donors were at higher risk for infection with GBV-C (P < 0.001) than controls. HCV RNA was detected more often in patients with GBV-C RNA than without (29/43 or 67%, vs. 14/36 or 39%, P < 0.05) as well as in commercial donors with GBV-C RNA than without (5/17 or 29% vs. 8/188 or 4%, P < 0.01). A phylogenetic tree constructed on a sequence of 100 base pairs in the helicase region indicated that GBV-C isolates from Beijing are more similar to Japanese isolates than to isolates from the United States and Africa. Sequences from certain hemodialysis patients and those from some commercial donors were similar, suggesting nosocomial infection and spread among restricted groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131454     DOI: 10.1002/(sici)1096-9071(199705)52:1<26::aid-jmv5>3.0.co;2-t

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

Review 1.  GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease.

Authors:  M Sathar; P Soni; D York
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

2.  Age related prevalence of hepatitis G virus in South Africans.

Authors:  M J Mphahlele; S Aspinall; R Spooner; W F Carman
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

3.  Lower hepatitis G virus infection prevalence compared to hepatitis B and C virus infection prevalences.

Authors:  N Furusyo; J Hayashi; I Ariyama; Y Sawayama; Y Etoh; S Kashiwagi
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

4.  Mix-infections with different genotypes of HCV and with HCV plus other hepatitis viruses in patients with hepatitis C in China.

Authors:  Yuan-Ding Chen; Ming-Ying Liu; Wen-Lin Yu; Jia-Qi Li; Qin Dai; Zhen-Quan Zhou; Sergio G Tisminetzky
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

5.  Hepatitis G virus infection in Egyptian children with chronic renal failure (single centre study).

Authors:  Ayman Mohammad Hammad; Mohammad Hosam El Deen Zaghloul
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-12-16       Impact factor: 3.944

6.  Hepatitis G virus exposure in dialysis patients.

Authors:  Ali Eslamifar; Rasool Hamkar; Amitis Ramezani; Farrokhlagha Ahmadi; Latif Gachkar; Somayeh Jalilvand; Ladan Adibi; Shahnaz Atabak; Ali Khameneh; Ramin Ghadimi; Arezoo Aghakhani
Journal:  Int Urol Nephrol       Date:  2007-09-05       Impact factor: 2.370

7.  Hepatitis G virus in the general population and in patients on hemodialysis.

Authors:  J Hayashi; N Furusyo; Y Sawayama; Y Kishihara; Y Kawakami; I Ariyama; Y Etoh; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

8.  Prevalence of GB virus type C viraemia in MSM with or without HIV-1 infection in Beijing, China.

Authors:  Z Liu; L Li; Z Chen; M Xu; T Zhang; Y Jiao; B Sheng; D Chen; H Wu
Journal:  Epidemiol Infect       Date:  2012-03-26       Impact factor: 4.434

Review 9.  Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis.

Authors:  Xiaofei Gao; Qian Cui; Xiang Shi; Jing Su; Zhihang Peng; Xin Chen; Na Lei; Keqin Ding; Lu Wang; Rongbin Yu; Ning Wang
Journal:  BMC Infect Dis       Date:  2011-04-09       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.